Menu
02
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- Africa
- Brexit
- Content & Brand
- Corporate Communications
- Development & Global Issues
- Digital
- Disputes
- Employee Engagement
- Events
- Financial Communications
- Geo-Political
- Health
- How Africa Tweets
- HR
- Local Government
- Philanthropy
- Portland News
- Public Affairs
- Research & Insights
- Soft Power
- Sport
- UK Politics
- Uncategorized
- US Presidential Election
In Other News…
While you weren’t looking, policy makers in Washington (and in several state capitals) have taken steps that could significantly reform and recast the drug pricing system in the US.
New priorities for the NHS will begin with bricks and mortar
The new PM – a man in a hurry – has made his priorities for his Health and Social Care Secretary clear.
Blazing a trail – the future of medical cannabis in global health
The medical cannabis industry has exploded over the last few years and is now truly entering the mainstream.
Trump doesn’t want the NHS
While visiting London last week, President Trump made a splash by seeming to suggest the NHS was of interest to the U.S. as part of a potential post-Brexit US/UK trade agreement.
Mandating Drug Prices in Ads May Lead to Consumer Hesitancy and Big Pharma Pushback
In early May, the Trump administration announced that it will require pharmaceutical companies to disclose the “list price” of their prescription drugs in direct-to-consumer television advertisements.
Health Perspective: Why Language Matters
In the Health Team, we consider language styles and how we use them as a priority. This comes down to the wide variety of stakeholders we engage with daily.
High demand low supply: NHS workforce challenges
With the Brexit deadline of 29th March fast approaching and almost half of the UK’s GPs planning to retire in next five years, the NHS is officially facing a workforce crisis.
State of the Union’s drug prices
Last night, US President Trump delivered his State of the Union message to Congress, the U.S. and the world.
Is the NHS plan enough to ward off Downing Street’s January blues?
Comprehensive and ambitious, the ‘NHS Long Term Plan’ provides practical solutions to the challenges an ageing population, funding pressures and growing demand will bring in coming years.
A tangled web: healthcare and the 116th Congress
The policy and political challenges facing both parties and President Trump are many. But one – issue healthcare – continues to dominate.
